Onset of amyopathic dermatomyositis following mRNA ‐based SARS‐CoV ‐2 vaccination
2022; Wiley; Volume: 36; Issue: 9 Linguagem: Inglês
10.1111/jdv.18211
ISSN1468-3083
AutoresAlexander Kreuter, Sara Lausch, Sven‐Niklas Burmann, Alexandros Paschos, Alena‐Lioba Michalowitz,
Tópico(s)Dermatological and Skeletal Disorders
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 36, Issue 9 p. e669-e672 Letter to the Editor Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination A. Kreuter, Corresponding Author A. Kreuter [email protected] orcid.org/0000-0003-2275-499X Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanyCorrespondence: A. Kreuter. E-mail: [email protected]Search for more papers by this authorS. Lausch, S. Lausch Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this authorS.-N. Burmann, S.-N. Burmann Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this authorA. Paschos, A. Paschos Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this authorA.-L. Michalowitz, A.-L. Michalowitz Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this author A. Kreuter, Corresponding Author A. Kreuter [email protected] orcid.org/0000-0003-2275-499X Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanyCorrespondence: A. Kreuter. E-mail: [email protected]Search for more papers by this authorS. Lausch, S. Lausch Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this authorS.-N. Burmann, S.-N. Burmann Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this authorA. Paschos, A. Paschos Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this authorA.-L. Michalowitz, A.-L. Michalowitz Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, GermanySearch for more papers by this author First published: 10 May 2022 https://doi.org/10.1111/jdv.18211Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume36, Issue9September 2022Pages e669-e672 This article also appears in:JEADV COVID-19 articles RelatedInformation
Referência(s)